Friday, June 28, 2013

Mesothelioma Stories - Bonnie Anderson Shares Mesothelioma Symptoms And Her Harrowing Experience

Here's the touching story of Bonnie Anderson, a peritoneal mesothelioma patient who survived the condition for 10 years now. This short documentary gives us an insight on what mesothelioma patients undergo through when they found out that they have mesothelioma symptoms and that they are positive of this rare case of cancer. Let's watch Bonnie as she talks about the mesothelioma symptoms that she experience, the diagnosis, the treatment and the hardship that she and her family has gone through until she survived the most painful chapter of her life.


Friday, June 14, 2013

Importance of Early Diagnosis of Mesothelioma Spurs Research for Better Blood Test


It’s very important to diagnose malignant pleural mesothelioma at the onset of the stage if patients want only the best outcome. And to hasten the benefits of early-stage mesothelioma diagnosis, researchers are working hard to come up with a reliable yet non-invasive procedures to identify the existence of mesothelioma symptoms.

An article published in the BMC Cancer journal reports of a Japan-based research which assessed the the “usefulness of the blood protein HMGB1 as a prognostic marker for mesothelioma,” reports AboutMesothelioma.net.

The research employed 106 participants who were exposed to asbestos at a certain point of their lives. After examining their blood samples, 61 individuals were found positive of malignant pleural mesothelioma, while 45 were diagnosed with non-malignant asbestos-related disease, including asbestosis, which is the scarring of the lungs.

Verastem's VS-6063 gets orphan drug status


Hope seems to be on its way to mesothelioma patients. Good news because the European Commission has just granted Verastem, Inc.’s VS-6063 the orphan status.

According to News-Medical.net, Verastem, Inc., has been working hard to discover and develop drugs that will treat cancer aiming at cancer stem cells.  

VS-6063’s orphan designation only serves to encourage the development of the drug, which will provide benefit to patients with mesothelioma cancer, as well as other diseases.

The drug-maker wants to begin “the randomized, double-blind, placebo controlled trial of VS-6063 in mesothelioma” within this year.

"We are pleased that the EMA recognizes the significant unmet medical need in mesothelioma," said Christoph Westphal, M.D., Ph.D., Verastem Chairman and Chief Executive Officer. "This orphan drug designation provides us with a number of benefits in the development of VS-6063."

Thursday, June 13, 2013

Radioactive Lead May Treat Cancer including Mesothelioma


Radioactive lead may treat cancer. This is if researchers at Areva Med in France succeeds in their experiment as they try to explore this procedure as a more effective treatment to cancers, including ovarian, gastric, pancreatic, cancers, especially the most dreaded of them all, mesothelioma cancers.

Areva’s research, as noted by AFP, features the use of the Pb212 isotope in fighting against antagonistic cancers. However, this isotope can be found only in very rare metals, like thorium. Only very few countries have stocks of this radioactive metal.

The study began in 2003, when researchers decided extracting the isotope when they had hints that this rare element is indeed effective in cancer treatment. When they saw signs of promise, Areva opened a medical affiliate in U.S. in 2009, continually working with the Pb212 in the U.S.

In 2011, together with physicians at the University of Alabama, Areva Med started the first phase of the clinical trial using radioimmunotherapy. The first of the 18 test patients started with therapy in April 2012. Areva Med chief Patrick Bourdet noted that the trial has been going well. If the progress goes on, Areva believes that their findings could be of long-term use.

Wednesday, June 12, 2013

Mother Of Three Dies Of Mesothelioma After Hugging Her Father When She Was A Child

Debbie Brewer, the mother-of-three who died of mesothelioma because
she hugged her father when she was a child.
Image credit: SWNS.com/Mail Online

Debbie Brewer spent seven years fighting mesothelioma cancer after contracting the disease by frequently hugging his father as a child, reports Mail Online.

Her father, Philip Northmore, worked as a lagger scraping asbestos from pipes at the British Royal Navy’s dockyard in Davenport. Northmore himself died of asbestos-related lung illness in 2006, the same year that his daughter was diagnoses with the long-dormant illness.

Mail Online reports that Northmore would come home every day from the dockyard virtually covered by asbestos. Debbie would rush to her father to give him a welcome hug, unknowingly killing herself in the long run.

In 2007, Debbie was awarded a six-figure sum by the Ministry of Defence who operated the dockyard after the agency admitted liability.

Tuesday, June 11, 2013

Volunteers Warned Against Mesothelioma Risk in Oklahoma


Oklahoma volunteers may be at risk from asbestos exposure. 
Volunteers from all over the country continue to head to storm-ravaged Oklahoma for the cleanup effort. But while their hard work and passion to helping others are hailed, they are however, warned against the threat of mesothelioma cancer. According to the Environmental Protection Agency (EPA), a lot of damaged homes and buildings in Moore, Oklahoma have been found to be exposed to different toxins. That includes asbestos, the number one cause of malignant mesothelioma.

While asbestos has long been phased out as among the construction materials, it is still present in large quantities in insulation, caulk and joint compound, floor and ceiling tiles, and shingles of old houses and buildings. In fact, a lot of establishments damaged by the hurricane are those that had been built between the late 50s and 1970s. This was the time when asbestos was the leading construction material. Although asbestos may not pose harm when buildings were intact, the risk, however, comes for anyone who unintentionally comes in contact with the hazardous material.

Early Stage Mesothelioma Symptoms You Should Watch Out


Mesothelioma cancer is a disease attributed to exposure to asbestos. It affects the mesothelium, the protective layer that covers some vital internal organs on the body. Early mesothelioma symptoms can be very elusive that victims tend to ignore them or feel that these symptoms do not need any medical attention. Oftentimes, these symptoms do not even manifest until the disease is already in a severe condition, and that medication is already too late to contain or cure mesothelioma.

Early Stage Mesothelioma Symptoms

Symptoms of mesothelioma cancer often manifest fifteen to twenty years after the victims’ exposure tot asbestos, and these symptoms vary. What are the factors of these variations? Well, for one the severity of the condition is a great factor; other factors include the immunity of the person to the condition and, of course, the anatomical area of the body where mesothelioma developed.

Friday, June 7, 2013

Mesothelioma Symptoms May Benefit from Tuberculosis Drugs


A person with mesothelioma may manifest pleural effusion, considered as one of the most excruciating and event life-limiting mesothelioma symptoms. Pleural effusion occurs with the excessive supply of fluid in the pleural space surrounding the lungs. This usually manifests in later stages of mesothelioma, although this may also afflict patients with other types of cancer.

This mesothelioma symptom restricts breathing and may even prove painful. In fact, effusion is considered one of the most common factors why late-stage mesothelioma patients have difficulty taking a full breath. Most of the time, they may even complain chest pain and fatigue.

Pleural effusion may be remedied by draining the fluid in two ways. One is thoracentesis, while the other is chemically absorbing pleura through pleurodesis. However, these treatments are not only agonizing but they don’t really guarantee complete  recovery for the patient.

Thursday, June 6, 2013

Determining Factors in Mesothelioma Compensation


Mesothelioma cancer is a kind of cancer that is characterized by the thickening of the mesothelium (the membrane that forms the lining of several body cavities). It develops on different anatomical sites of the body, and among the most common are pleural, peritoneal, pericardial, and testicular mesothelioma. The cause of this disease has always been attributed to asbestos exposure, which has also different reasons. There are also different ways how a person can be exposed to asbestos, but the most common reasons are occupational and residential exposures. People who work or live in places where asbestos is abundant are at higher risks in developing mesothelioma.

However, regardless of the reasons, some people are able to file compensation lawsuits against companies that are responsible for their asbestos exposure when they have already been diagnosed with mesothelioma. Asbestos is highly regarded as a health hazard, and companies distributing such materials (health hazards) are liable for the damages they cause. However still, not all who filed such lawsuits were compensated. Why? Because there are serious factors that are being considered before a decision for compensation is made. Here are some of them.

Australian Government to invest more than $10.5M for asbestos safety


In response to the rising cases of mesothelioma, the Australian Government is set to invest more than $10.5 million to mobilize a national campaign in an effort to protect everyone from asbestos-related diseases, revealed Employment and Workplace Relations Minister Bill Shorten last Tuesday.

In an interview, Shortin said, “Asbestos is a cruel, indiscriminate killer, and because of its widespread use over much of the 20th century, it remains a persistent threat to Australians.”

The aggressive campaign against mesothelioma cancer was launched after more 600 Australians died from mesothelioma in  2010. “For every death attributed to mesothelioma, it’s estimated two further people die from lung cancer caused by exposure to asbestos,” Shortin explained.

“Over the next 20 years, up to 40,000 Australians are expected to be diagnosed with an asbestos-related disease. There are children not yet born who’ll die of an asbestos-related disease,” he added.